Molekule Group (Molekule Group) Cash, Cash Equivalents, Marketable Securities : $5.27 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Cash, Cash Equivalents, Marketable Securities?

Molekule Group's quarterly cash, cash equivalents, marketable securities declined from Dec. 2022 ($22.06 Mil) to Mar. 2023 ($7.29 Mil) but then stayed the same from Mar. 2023 ($7.29 Mil) to Jun. 2023 ($5.27 Mil).

Molekule Group's annual cash, cash equivalents, marketable securities increased from Dec. 2020 ($2.33 Mil) to Dec. 2021 ($19.63 Mil) and increased from Dec. 2021 ($19.63 Mil) to Dec. 2022 ($22.06 Mil).

Molekule Group Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Molekule Group's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Cash, Cash Equivalents, Marketable Securities Chart

Molekule Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Cash, Cash Equivalents, Marketable Securities

2.33

19.63

22.06

Molekule Group Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial									29.16	25.82	22.06	7.29	5.27

Molekule Group Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Molekule Group (OTCPK:MKULQ) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Molekule Group Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Molekule Group's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Molekule Group (Molekule Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410

Website

https://www.molekule.com

Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.

Executives

Ritankar Pal	officer: Chief Operating Officer	10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410
Jonathan Harris	officer: Chief Commercial Officer	3000 CLEARVIEW WAY, SAN MATEO CA 94402
Bradley A Feld	director	C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302
Ryan A Mcintyre	10 percent owner
Seth Levine	10 percent owner	1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Fg Next Gp, Llc	10 percent owner	1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Foundry Group Next, L.p.	10 percent owner	C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302
Ward Jr Stephen M	director	C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612
Timothy J Scannell	director	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Heather Floyd	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Thomas P Mccaffrey	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Lewis C Pell	10 percent owner	C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760
Michael F Senft	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Jason Dibona	officer: Chief Executive Officer	10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410
David Helfet	director	10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410